drugset / Trial / NCT03329183
High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial aims to evaluate the efficacy, safety of high-dose FOLFIRI regimen in advanced colorectal cancer patients with wild-type UGT1A1\*6 and \*28.
Timeline
- Start
- 2019-03
- Primary completion
- 2019-03
- Completion
- 2022-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 260 mg/m2 | — |